Historical Background
A-RAF is a member of the RAF family of serine/threonine protein kinases comprising A-RAF B-RAF and RAF-1. In 1983 and 1986, the viral homologues of RAF were isolated during experiments with the aim to identify novel transforming genes. Viral RAF (v-RAF) homologus were encountered in two different viruses, the avian retrovirus Mill Hill 2 (MH2) and the murine sarcoma virus (MSV) 3611. While MH2 was isolated from a spontaneous chicken ovarian tumor, 3611-MSV was isolated from a mouse with lymphoma and lung adenocarcinoma. The name RAF derives from the observation that 3611-MSV increased the induction of fibrosarcoma in newborn NSF/N mice (rapidly accelerated fibrosarcoma, or RAF). These v-RAF genes originate from the mammalian proto-oncogene RAF-1 (or C-RAF) having incorporated the truncated CRAF kinase domain...
This is a preview of subscription content, log in via an institution to check access.
References
We apologize to all the colleagues, whose work, for reasons of space, could not be cited in this review.
Baljuls A, Mueller T, Drexler H, Hekman M, Rapp U. Unique N-region determines low basal activity and limited inducibility of A-RAF kinase: the role of N-region in the evolutionary divergence of RAF kinase function in vertebrates. J Biol Chem. 2007;282:26575–90. doi:10.1074/jbc.M702429200.
Baljuls A, Schmitz W, Mueller T, Zahedi R, Sickmann A, Hekman M, et al. Positive regulation of A-RAF by phosphorylation of isoform-specific hinge segment and identification of novel phosphorylation sites. J Biol Chem. 2008;283:27239–54. doi:10.1074/jbc.M801782200.
Farrell J, Kelly C, Rauch J, Kida K, Garcia-Muñoz A, Monsefi N, et al. HGF induces epithelial-to-mesenchymal transition by modulating the mammalian hippo/MST2 and ISG15 pathways. J Proteome Res. 2014;13:2874–86. doi:10.1021/pr5000285.
Huleihel M, Goldsborough M, Cleveland J, Gunnell M, Bonner T, Rapp U. Characterization of murine A-raf, a new oncogene related to the v-raf oncogene. Mol Cell Biol. 1986;6:2655–62.
Imielinski M, Greulich H, Kaplan B, Araujo L, Amann J, Horn L, et al. Oncogenic and sorafenib-sensitive ARAF mutations in lung adenocarcinoma. J Clin Invest. 2014;124:1582–6. doi:10.1172/JCI72763.
Johnson L, James K, Chamberlain M, Anderson D. Identification of key residues in the A-Raf kinase important for phosphoinositide lipid binding specificity. Biochemistry. 2005;44:3432–40. doi:10.1021/bi0487692.
Liu L, Channavajhala P, Rao V, Moutsatsos I, Wu L, Zhang Y, et al. Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim Biophys Acta. 2009;1794:1485–95. doi:10.1016/j.bbapap.2009.06.016.
Liu X, Xiong C, Jia S, Zhang Y, Chen Y-G, Wang Q, et al. Araf kinase antagonizes Nodal-Smad2 activity in mesendoderm development by directly phosphorylating the Smad2 linker region. Nat Commun. 2013;4:1728. doi:10.1038/ncomms2762.
Matallanas D, Birtwistle M, Romano D, Zebisch A, Rauch J, von Kriegsheim A, et al. Raf family kinases: old dogs have learned new tricks. Genes Cancer. 2011;2:232–60. doi:10.1177/1947601911407323.
Mooz J, Oberoi-Khanuja TK, Harms GS, Wang W, Jaiswal BS, Seshagiri S, et al. Dimerization of the kinase ARAF promotes MAPK pathway activation and cell migration. Sci Signal. 2014;7:ra73. doi:10.1126/scisignal.2005484.
Nelson DS, Quispel W, Badalian-Very G, van Halteren AGS, van den Bos C, Bovee JVMG, et al. Somatic activating ARAF mutations in Langerhans cell histiocytosis. Blood. 2014;123:3152–5. doi:10.1182/blood-2013-06-511139.
Pritchard C, Bolin L, Slattery R, Murray R, McMahon M. Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene. Curr Biol. 1996;6:614–7.
Rauch J, Moran-Jones K, Albrecht V, Schwarzl T, Hunter K, Gires O, et al. c-Myc regulates RNA splicing of the A-Raf kinase and its activation of the ERK pathway. Cancer Res. 2011;71:4664–74. doi:10.1158/0008-5472.CAN-10-4447.
Rauch J, O’Neill E, Mack B, Matthias C, Munz M, Kolch W, et al. Heterogeneous nuclear ribonucleoprotein H blocks MST2-mediated apoptosis in cancer cells by regulating A-Raf transcription. Cancer Res. 2010;70:1679–88. doi:10.1158/0008-5472.CAN-09-2740.
Rauch J, Vandamme D, Mack B, McCann B, Volinsky N, Blanco A, et al. Differential localization of A-Raf regulates MST2-mediated apoptosis during epithelial differentiation. Cell Death Differ. 2016; doi:10.1038/cdd.2016.2.
Rebocho AP, Marais R. ARAF acts as a scaffold to stabilize BRAF:CRAF heterodimers. Oncogene. 2013;32:3207–12. doi:10.1038/onc.2012.330.
Rushworth L, Hindley A, O’Neill E, Kolch W. Regulation and role of Raf-1/B-Raf heterodimerization. Mol Cell Biol. 2006;26:2262–72.
Shilo A, Ben Hur V, Denichenko P, Stein I, Pikarsky E, Rauch J, et al. Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development. RNA. 2014;20:505–15. doi:10.1261/rna.042259.113.
Sia D, Losic B, Moeini A, Cabellos L, Hao K, Revill K, et al. Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. Nat Commun. 2015;6:6087. doi:10.1038/ncomms7087.
Yokoyama T, Takano K, Yoshida A, Katada F, Sun P, Takenawa T, et al. DA-Raf1, a competent intrinsic dominant-negative antagonist of the Ras-ERK pathway, is required for myogenic differentiation. J Cell Biol. 2007;177:781–93.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media LLC
About this entry
Cite this entry
Rauch, J., Kolch, W. (2016). A-RAF. In: Choi, S. (eds) Encyclopedia of Signaling Molecules. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-6438-9_610-1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-6438-9_610-1
Received:
Accepted:
Published:
Publisher Name: Springer, New York, NY
Online ISBN: 978-1-4614-6438-9
eBook Packages: Springer Reference Biomedicine and Life SciencesReference Module Biomedical and Life Sciences